Open access
Sep 2026
Drug repurposing of glycerol phenylbutyrate for children with SLC6A1-related neurodevelopmental disorder: A prospective open-label case series.
Glycerol phenylbutyrate was associated with improvements in individualized outcomes in children with SLC6A1-NDD, however, personalized goal attainment measures are susceptible to expectation and observer bias in open-label study designs.
E. V. van Walree, D. Dekker, J. Sprengers et al.
· Molecular Genetics and Metab... · 0 citations